Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
收藏数据链接：
官方服务：
资源简介：
Evidence for ctDNA estimates per patient per timepoint
创建时间：
2023-08-01
